SCHEMBL3544176

SCHEMBL3544176

COC(=O)[C@H]1C[C@H](OO)CN1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 3/20 0.40
KMT2A Q03164 1/20 0.40
KCNN4 O15554 1/20 0.36
ANPEP P15144 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
CHRM2 P08172 5/20 0.34
CHRM4 P08173 5/20 0.34
CHRM5 P08912 5/20 0.34
CHRM1 P11229 5/20 0.34
CHRM3 P20309 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202136 1.00 MMP2 (0.40) MMP2KMT2AKCNN4ANPEPCYP1A2
SCHEMBL3832522 0.91 MMP2 (0.41) MMP2KMT2AKCNN4ANPEPCYP1A2
SCHEMBL6586331 0.91 MMP2 (0.41) MMP2KMT2AKCNN4ANPEPCYP1A2
SCHEMBL3549930 0.85 HTR3E (0.45) MMP2KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL29276109 0.85 MMP2 (0.45) MMP2KMT2AKCNN4ANPEPCYP3A4
SCHEMBL30214730 0.85 MMP2 (0.45) MMP2KMT2AKCNN4ANPEPCYP3A4
SCHEMBL5205550 0.85 HTR3E (0.45) MMP2KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL29276107 0.85 MMP2 (0.45) MMP2KMT2AKCNN4ANPEPCYP3A4
SCHEMBL992574 0.84 KCNN4 (0.43) MMP2KMT2AKCNN4ANPEPCYP1A2
SCHEMBL2298094 0.84 KCNN4 (0.43) MMP2KMT2AKCNN4ANPEPCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE MMP2 1277/4885KMT2A 1078/4885KCNN4 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.